167 related articles for article (PubMed ID: 8877033)
1. Influence of liver cirrhosis on sertraline pharmacokinetics.
Démolis JL; Angebaud P; Grangé JD; Coates P; Funck-Brentano C; Jaillon P
Br J Clin Pharmacol; 1996 Sep; 42(3):394-7. PubMed ID: 8877033
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.
Ronfeld RA; Tremaine LM; Wilner KD
Clin Pharmacokinet; 1997; 32 Suppl 1():22-30. PubMed ID: 9068932
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
Preskorn SH; Alderman J; Chung M; Harrison W; Messig M; Harris S
J Clin Psychopharmacol; 1994 Apr; 14(2):90-8. PubMed ID: 8195463
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting.
Stock AJ; Kofoed L
Am J Hosp Pharm; 1994 Sep; 51(18):2279-81. PubMed ID: 7801990
[No Abstract] [Full Text] [Related]
5. Sertraline. Chronopharmacokinetics and the effect of coadministration with food.
Ronfeld RA; Wilner KD; Baris BA
Clin Pharmacokinet; 1997; 32 Suppl 1():50-5. PubMed ID: 9068936
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of the pharmacology of sertraline.
Warrington SJ
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
[TBL] [Abstract][Full Text] [Related]
7. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Murdoch D; McTavish D
Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
[TBL] [Abstract][Full Text] [Related]
8. Hemodialyzability of sertraline.
Schwenk MH; Verga MA; Wagner JD
Clin Nephrol; 1995 Aug; 44(2):121-4. PubMed ID: 8529300
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the newer antidepressants.
Burke MJ; Harvey AT; Preskorn SH
Am J Med; 1996 Jan; 100(1):119-21. PubMed ID: 8579077
[No Abstract] [Full Text] [Related]
10. Withdrawal reaction after sertraline discontinuation.
Louie AK; Lannon RA; Ajari LJ
Am J Psychiatry; 1994 Mar; 151(3):450-1. PubMed ID: 8109661
[No Abstract] [Full Text] [Related]
11. Sertraline concentrations and postmortem redistribution.
McIntyre IM; Mallett P
Forensic Sci Int; 2012 Nov; 223(1-3):349-52. PubMed ID: 23131307
[TBL] [Abstract][Full Text] [Related]
12. Interactions between sertraline and tricyclic antidepressants.
Lydiard RB; Anton RF; Cunningham T
Am J Psychiatry; 1993 Jul; 150(7):1125-6. PubMed ID: 8317590
[No Abstract] [Full Text] [Related]
13. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.
Hamelin BA; Turgeon J; Vallée F; Bélanger PM; Paquet F; LeBel M
Clin Pharmacol Ther; 1996 Nov; 60(5):512-21. PubMed ID: 8941024
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
15. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Preskorn S
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
[TBL] [Abstract][Full Text] [Related]
16. An interaction of sertraline and desipramine.
Barros J; Asnis G
Am J Psychiatry; 1993 Nov; 150(11):1751. PubMed ID: 8214190
[No Abstract] [Full Text] [Related]
17. The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
Kurtz DL; Bergstrom RF; Goldberg MJ; Cerimele BJ
Clin Pharmacol Ther; 1997 Aug; 62(2):145-56. PubMed ID: 9284850
[TBL] [Abstract][Full Text] [Related]
18. Distribution of sertraline in postmortem cases.
Levine B; Jenkins AJ; Smialek JE
J Anal Toxicol; 1994 Sep; 18(5):272-4. PubMed ID: 7990446
[TBL] [Abstract][Full Text] [Related]
19. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
Alderman J; Wolkow R; Chung M; Johnston HF
J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
[TBL] [Abstract][Full Text] [Related]
20. [Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant].
Kölling P; Jansen Steur EN; de Burlet HM
Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1467-8. PubMed ID: 8766773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
